Navigation Links
Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion
Date:10/29/2008

IRVINE, Calif., Oct. 29 /PRNewswire/ -- Irvine Pharmaceutical Services, Inc., announced today that as part of its ongoing efforts to identify and meet current and future industry demands, the company has promoted Aryo Nikopour to Vice President of Scientific and Technical Services and added to its staff Chief Operating Officer Greg McParland. These changes come at an opportune time in the company's growth as it gears up to launch its new subsidiary, Avrio Biopharmaceuticals, in January 2009.

After five years at Irvine and with a cumulative 20-plus years experience in the pharmaceutical industry, Aryo Nikopour offers to his new position a solid understanding and knowledge of the company as well as pharmaceutical development. His previous positions at highly reputable organizations such as PPD, Alpharma (Actavis), Solvay Pharmaceuticals and Solvay Animal Health, to name a few, has helped develop his expertise in a range of areas, including chromatographic method development and validation, Extractables/Leachables studies, and implementation of new technologies and capabilities such as Inhalation/Nasal, Biopharmaceutical and Structural Chemistry. Nikopour also has strong experience in scientific staff management, quality control, stability testing and regulatory requirements.

Greg McParland brings to Irvine more than 30 years of experience in the pharmaceutical and chemical industries. Prior to joining Irvine, McParland was Chief Executive Officer of Girindus America Inc., a member of Solvay Organics. There, McParland lead the R&D focused company through a major transition to become a commercial operation focused on small molecule and oligonucleotide active pharmaceutical ingredients. His additional leadership experience at companies such as Cambrex Corporation, Altergy Systems, NextPharma and Aerojet Fine Chemicals, in the areas of operations, sales and marketing, strategic planning, process optimization, and mergers and acquisitions, will be invaluable to both Irvine Pharmaceuticals and its new company, Avrio Biopharmaceuticals.

"We are looking forward to continued growth under the leadership of Aryo Nikopour and Greg McParland," said Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services. "I am confident they will lead us to even greater success as we expand and work to provide ever improving services to our clients."

Since early 2007, Irvine Pharmaceutical Services, Inc., has experienced extensive growth, and has made significant upgrades in its lab equipment and infrastructure. You can meet Irvine staff and learn more about the company at the AAPS Annual Meeting, booth 1707.

About Irvine

Irvine Pharmaceutical Services, Inc. is a fully integrated services provider that works with pharmaceutical, biotechnology and medical device companies through all phases of research and development. Founded in 1988 and committed to expansion and services that benefit its clients' priorities directly, Irvine is a fully cGMP compliant contract testing laboratory located in Irvine, CA. Visit http://www.irvinepharma.com or call (877) 445-6554.


'/>"/>
SOURCE Irvine Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hoag Hospital Announces Agreement to Open Irvine Campus
2. Lucas Group to Host Military Hiring Conferences in Washington, DC; Irvine, CA and Dallas, TX
3. UC Irvine to lead statewide program on green materials research
4. UC Irvine researchers present latest findings at emergency medicine forum
5. UC-Irvine scientists present groundbreaking research at Society for Neuroscience conference
6. Watson Pharmaceuticals Reports Third Quarter 2008 Results
7. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
8. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R)
11. WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... Bill ... management industry in the coastal communities. After Tina Howe joined the team, the Bill ... happy employees, honest services at affordable rates, and giving back to the San Diego ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology: